Johnson & Johnson MedTech Highlights Newest Impella Heart Pump and Long-Term Survival Data at TCT 2025

Written by

in

Danvers, MA – Oct 24, 2025 – Johnson & Johnson MedTech, a global leader in heart recovery, will feature the latest long-term data confirming the survival benefit of Impella CP and present the newest Impella…

Continue Reading

More posts

Facilitated Telemedicine Boosts Healthcare Access

October 24, 2025
Northampton factory making counterfeit weight-loss jabs raided | Drugs trade

October 24, 2025
Just a moment…

October 24, 2025
Establishing optimal cut-offs of cardio-metabolic indices for diagnosing metabolic syndrome in type 2 diabetes | BMC Endocrine Disorders

October 24, 2025